Sign in

CIK 0001827635

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Veradermics, Inc

Sign in to watch
Ticker
MANE
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843304423
Phone
+1 228-372-3376
Business address
470 JAMES STREET, NEW HAVEN, CT, 06513
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$230,817,500
in 3 filings

Net −$230,817,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-17 Durso Timothy August Chief Technical Officer Option exercise 10b5-1 +3,452 $12.19 $42K 121,642
2026-08-17 Durso Timothy August Chief Technical Officer Sale 10b5-1 −7,918 $106.71 $845K 113,724
2026-08-17 Durso Timothy August Chief Technical Officer Sale 10b5-1 −16,306 $107.52 $1.8M 97,418
2026-08-17 Durso Timothy August Chief Technical Officer Sale 10b5-1 −16,767 $108.38 $1.8M 80,651
2026-08-17 Durso Timothy August Chief Technical Officer Sale 10b5-1 −2,348 $109.34 $257K 78,303
2026-08-17 Durso Timothy August Chief Technical Officer Sale 10b5-1 −161 $111.28 $18K 78,142
2026-08-17 Durso Timothy August Chief Technical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −3,452 0
2026-02-05 Durso Timothy August Chief Technical Officer Conversion +1,473 118,190
2026-02-05 Durso Timothy August Chief Technical Officer Conversion · Series A Convertible Preferred Stock −1,473 0
2026-02-03 Durso Timothy August Chief Technical Officer Grant or award · Stock Option (Right to Buy) +213,352 213,352

Page 1 of 1 · 10 trades